Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine versus placebo on central aortic blood pressure in stable coronary artery disease with type 2 diabetes
2011-004779-35Phase 2Terminated
- Sponsor
- Servier
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivabradine in coronary arteriosclerosis (2 arms), sponsored by Servier. Primary endpoint: Central aortic systolic blood pressure. Started Mar 2012; status: terminated.
02
Drugs
ivabradine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-004779-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004779-35.